Stock Scorecard
Stock Summary for Nutex Health Inc (NUTX) - $28.10 as of 11/19/2024 8:34:43 AM EST
Total Score
11 out of 30
Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for NUTX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NUTX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NUTX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NUTX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NUTX (34 out of 90)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 3 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for NUTX
Financial Details for NUTX
Company Overview |
|
|---|---|
| Ticker | NUTX |
| Company Name | Nutex Health Inc |
| Country | USA |
| Description | Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas. |
| Sector Name | TRADE & SERVICES |
| Industry Name | SERVICES-BUSINESS SERVICES, NEC |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 28.10 |
| Price 4 Years Ago | 202.50 |
| Last Day Price Updated | 11/19/2024 8:34:43 AM EST |
| Last Day Volume | 61,186 |
| Average Daily Volume | 64,389 |
| 52-Week High | 39.48 |
| 52-Week Low | 4.16 |
| Last Price to 52 Week Low | 575.48% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 49.14 |
| Sector PE | 41.04 |
| 5-Year Average PE | -213.09 |
| Free Cash Flow Ratio | 3.26 |
| Industry Free Cash Flow Ratio | 101.30 |
| Sector Free Cash Flow Ratio | 94.88 |
| Current Ratio Most Recent Quarter | 1.77 |
| Total Cash Per Share | 8.63 |
| Book Value Per Share Most Recent Quarter | 11.59 |
| Price to Book Ratio | 2.58 |
| Industry Price to Book Ratio | 8.04 |
| Sector Price to Book Ratio | 9.15 |
| Price to Sales Ratio Twelve Trailing Months | 0.53 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.90 |
| Sector Price to Sales Ratio Twelve Trailing Months | 2.18 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 5,437,000 |
| Market Capitalization | 152,779,700 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 89.22% |
| Reported EPS 12 Trailing Months | -9.18 |
| Reported EPS Past Year | -1.85 |
| Reported EPS Prior Year | -0.08 |
| Net Income Twelve Trailing Months | -41,134,333 |
| Net Income Past Year | -45,786,614 |
| Net Income Prior Year | -424,780,446 |
| Quarterly Revenue Growth YOY | 25.60% |
| 5-Year Revenue Growth | 182.89% |
| Operating Margin Twelve Trailing Months | 0.13 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 46,909,281 |
| Total Cash Past Year | 22,002,056 |
| Total Cash Prior Year | 34,255,264 |
| Net Cash Position Most Recent Quarter | 2,838,904 |
| Net Cash Position Past Year | -59,017,694 |
| Long Term Debt Past Year | 81,019,750 |
| Long Term Debt Prior Year | 80,351,099 |
| Total Debt Most Recent Quarter | 44,070,377 |
| Equity to Debt Ratio Past Year | 0.43 |
| Equity to Debt Ratio Most Recent Quarter | 0.58 |
| Total Stockholder Equity Past Year | 61,453,190 |
| Total Stockholder Equity Prior Year | 95,862,701 |
| Total Stockholder Equity Most Recent Quarter | 60,440,693 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 20,241,131 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.72 |
| Free Cash Flow Past Year | -9,279,537 |
| Free Cash Flow Prior Year | 35,974,694 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 2.57 |
| MACD Signal | 2.14 |
| 20-Day Bollinger Lower Band | 3.88 |
| 20-Day Bollinger Middle Band | 19.25 |
| 20-Day Bollinger Upper Band | 34.62 |
| Beta | 1.79 |
| RSI | 56.53 |
| 50-Day SMA | 240.01 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 298.15 |
System |
|
| Modified | 11/19/2024 8:35:33 AM EST |